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Introduction
Laia Catalan Diaz – June 2017
The sentinel lymph node (SLN) is the first lymph node (LN) within a lymphatic drainage basin to which a primary tumor reliably drains. The mapping and
selective biopsy consists on localize the SLN and remove it surgically for histopathological analysis. If the result is positive, it means that SLN has
metastatic cells so radical lymphadenectomy (LAD) is needed. If the result is negative, it means that the rest of the lymphatic drainage is free of disease
and therefore surgical excision of the LNs is not necessary performed. The main aim of this work is to make a review of different mapping techniques and
to analyze its feasibility to be applied as a routine in LNs evaluation in canine oncological patients.
Situation in veterinary medicineSituation in human medicine
Alternative techniques for mapping SLN
Importance of SLN identification
SLN biopsy is well established as a standard step of staging in
mammary gland tumors and melanoma. The procedure applied is:
Conclusions
The mapping and selective biopsy of SLN is not used as a staging routine in the
most frequent canine tumors: melanoma, mastocytoma and mammary gland tumor.
Currently, the methods used to evaluate the status of LNs are palpation and fine
needle aspiration cytology. The main disadvantages are:
• Low sensitivity and specificity  inflammation also increase LNs size.
• Micrometastases take long time to produce palpable lymphadenomegaly.
• Difficult anatomical localization of LNs.
• Unrepresentative sample.
• Not all LNs are susceptible to be aspirated.
• It can’t determine the degree of infiltration of tumor cells and the relation
between them.
The regional LNs are not always the SLN because of the
lymhangiogenesis related with tumors. This technique allows:
• Individually identification of the drainage pattern of each patient.
• An accurate staging of tumors that marks the therapeutic
protocol  adjuvant therapies as radiotherapy and
chemotherapy are administered in advanced stages.
• SLN biopsy should be an essential step of the staging process and a
minimum invasive alternative to radical LAD.
• It is recommended the use of mapping techniques for the characterization
of lymphatic drainage due to its variation associated with tumor processes.
• The most feasible and valid technique to be implemented is the indirect
lymphography combined with methylene blue dye injection.
• Increased owner concern and percentage of tumoral processes make
mapping and selective biopsy a good tool to be applied in the near future
in veterinary practice.
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Technique
Lymphoscintigraphy or 
gammagraphy (Fig.1)
Indirect lymphography by 
X-ray (Fig.2a)
Indirect lymphography by 
CT (Fig.2b)
Contrast-enhanced 
ultrasound (Fig.3)
Fluorescein and patent 
blue dyes (Fig.4)
Contrast 99mTc-Labeled dextran Lipiodol Ultrafluid TM Lipiodol Ultrafluid TM
Octafluoropropane-filled lipid 
microspheres
Methylene blue and 
fluorescein
Advantages Disadvantages
1
Highest sensitivity and specificity
Visualization of small and deep LNs
High cost
Radioactivity contrast
2
Liposoluble contrast
Guide to perform radiotherapy 
treatments
Less sensitivity and specificity 
than lymphoscintigraphy
3
Not radioactivity contrast
Easy to perform and low cost
Difficult to biopsy deep LNs
Not representative samples
4 Easy, cheap and available Lowest sensitivity used alone
Figure 1. Ventral
gammagraphy. The
image shows the
activity of axillary
(Ax), cranial sternal
(Sc), and superficial
cervical (Cs) LN1s1.
Figure 2a. Lateral X ray
24h after intradermal
injection of the contrast.
Long arrows indicate the
contrast-enhanced
popliteal LN2.
Figure 2b. Transverse
CT-LG. The image shows
the spotted appearance
of an enlarged SLN
(asterisk indicates the 5th
mammary gland)3.
Figure 3. Screen capture of an ultrasound image.
Left image: normal hypoechoic LN (arrow). Right
image: the contrast is in a lymphatic channel
(arrowhead) beginning to fill LN (thin arrow)4.
Figure 4. Methylene blue
drainage from mouth and lip
in malignant melanoma5.
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